Eli Lilly and (LLY) Business Metric Overview - Stocknear

Eli Lilly and

NYSE: LLY · Real-Time Price · USD
738.59
11.38 (1.56%)
At close: Sep 08, 2025, 3:59 PM
737.40
-0.16%
After-hours: Sep 08, 2025, 07:59 PM EDT

Eli Lilly and Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011 Sep 30, 2010
Cardiometabolic Health Revenue 11.34B 9.21B 7.41B 7.51B 834M 986.9M 928.5M 777.8M 866.4M 796.5M 748.1M 1B 785.4M 613.9M 627.1M 548.3M 585.8M 454.6M 456.1M 334.7M 966.9M 861.3M 922.6M 759M 887.9M 869.9M 893.7M 964.4M 1.48B 1.88B 2B 1.85B 2.03B 1.82B 1.82B 1.9B 2.49B 2.65B 2.41B 2.25B
Cardiometabolic Health Revenue Growth +23.18% +24.32% -1.43% +801.03% -15.49% +6.29% +19.38% -10.23% +8.78% +6.47% -25.55% +27.95% +27.94% -2.10% +14.37% -6.40% +28.86% -0.33% +36.27% -65.38% +12.26% -6.64% +21.55% -14.52% +2.07% -2.66% -7.33% -35.05% -20.94% -6.31% +8.42% -8.98% +11.86% -0.48% -4.16% -23.48% -6.25% +10.34% +7.06% n/a
Immunology Revenue 1.26B 1.09B 1.19B 1.08B 552.5M 1.77B 387.2M 360.5M 433.8M 459.5M 471.9M 526.7M 597.1M 538.9M 470.7M 422.5M 463.5M 426.7M 452.7M 393.1M 721.7M 724.5M 763.9M 725.3M 868.5M 882.4M 858.4M 764.3M 874.4M 821.8M 808.1M 764.2M 839.2M 791.7M 846.8M 803.9M 817.8M 825.8M 839.9M 980.3M
Immunology Revenue Growth +15.40% -8.24% +9.54% +95.91% -68.75% +356.64% +7.41% -16.90% -5.59% -2.63% -10.40% -11.79% +10.80% +14.49% +11.41% -8.85% +8.62% -5.74% +15.16% -45.53% -0.39% -5.16% +5.32% -16.49% -1.58% +2.80% +12.31% -12.59% +6.40% +1.70% +5.74% -8.94% +6.00% -6.51% +5.34% -1.70% -0.97% -1.68% -14.32% n/a
Neuroscience Revenue 344M 272.1M 469M 487M 2.08B 1.75B 1.67B 1.36B 1.4B 1.48B 1.45B 1.51B 1.64B 1.44B 1.33B 1.27B 1.2B 1.15B 1.2B 1.01B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Neuroscience Revenue Growth +26.42% -41.98% -3.70% -76.57% +18.97% +4.55% +23.23% -2.84% -5.41% +1.46% -3.47% -7.89% +13.27% +8.28% +5.11% +5.58% +4.72% -4.16% +18.22% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oncology Revenue 2.41B 1.95B 2.56B 2.46B 241.9M 276.1M 314.6M 275.3M 746M 494.7M 1.92B 637.7M 712.9M 1.24B 526.4M 481M 640.1M 303.5M 323.5M 421.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oncology Revenue Growth +23.93% -23.81% +4.00% +916.04% -12.39% -12.24% +14.28% -63.10% +50.80% -74.27% +201.55% -10.55% -42.64% +136.11% +9.44% -24.86% +110.91% -6.18% -23.27% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Product, Total Revenue 201.5M 212.9M 262.8M 207.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Product, Total Revenue Growth -5.35% -18.99% +26.59% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
China Revenue 465.9M 450.8M 429.2M 459.9M 395.1M 376.2M 377.2M 390.8M 399M 372.7M 350.8M 343.4M 352.1M 406.5M 376.4M 400.3M 522.5M 362.2M 320.7M 289.1M 239.8M 267.3M 1.01B 923.4M 928.2M 900.3M 1.09B 1.02B 1.09B 3.15B
China Revenue Growth +3.35% +5.03% -6.68% +16.40% +5.02% -0.27% -3.48% -2.06% +7.06% +6.24% +2.15% -2.47% -13.38% +8.00% -5.97% -23.39% +44.26% +12.94% +10.93% +20.56% -10.29% -73.62% +9.71% -0.52% +3.10% -17.27% +7.00% -6.76% -65.43% n/a
Europe Revenue 2.57B 2.39B 2.45B 1.63B 1.4B 1.44B 1.34B 2.57B 1.18B 1.09B 1.07B 1.06B 1.1B 1.07B 1.15B 1.1B 1.21B 1.32B 1.21B 1.05B 873M 1.06B 709.2M 641.5M 653.2M 543.7M 6.33B 3.6B 3.75B 1.04B
Europe Revenue Growth +7.77% -2.42% +50.34% +16.00% -2.57% +7.71% -47.92% +118.12% +7.95% +1.54% +1.70% -4.06% +3.17% -6.96% +4.42% -9.19% -8.43% +9.46% +15.31% +19.90% -17.72% +49.61% +10.55% -1.79% +20.14% -91.40% +75.48% -3.91% +262.39% n/a
Japan Revenue 521M 402.2M 559.2M 429.1M 462.7M 363.9M 439M 390.8M 455.6M 387.2M 395M 487.7M 454.4M 410.2M 534.8M 595M 665.4M 571.8M 664M 660.1M 666.7M 592.3M 3.52B 3.06B 3.25B 2.89B 664.8M 608.8M 664.3M 555.8M
Japan Revenue Growth +29.54% -28.08% +30.32% -7.26% +27.15% -17.11% +12.33% -14.22% +17.67% -1.97% -19.01% +7.33% +10.78% -23.30% -10.12% -10.58% +16.37% -13.89% +0.59% -0.99% +12.56% -83.17% +15.00% -5.91% +12.51% +334.84% +9.20% -8.35% +19.52% n/a
Non-Us Revenue 1.18B 997.4M 1.06B 1.11B 1.21B 892.9M 744.3M 780.3M 748.5M 673.1M 822.8M 632M 645.7M 751.5M 765.6M 689.4M 638.1M 609.1M 4.59B 3.16B 3.14B 3.33B n/a n/a n/a n/a n/a n/a n/a n/a
Non-Us Revenue Growth +18.52% -6.28% -3.97% -8.12% +35.08% +19.97% -4.61% +4.25% +11.20% -18.19% +30.19% -2.12% -14.08% -1.84% +11.05% +8.04% +4.76% -86.74% +45.32% +0.53% -5.53% n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 10.81B 8.49B 9.03B 7.81B 7.84B 5.69B 6.46B 5.37B 5.53B 4.44B 4.66B 4.42B 3.93B 5.17B 5.18B 3.99B 3.7B 3.94B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +27.38% -6.01% +15.59% -0.28% +37.59% -11.79% +20.25% -2.95% +24.69% -4.77% +5.35% +12.38% -23.96% -0.03% +29.73% +7.70% -6.02% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.65B 2.36B 2.31B 1.98B 2B 1.84B 1.81B 1.69B 1.81B 1.63B 1.55B 1.52B 1.53B 1.46B 1.52B 1.51B 1.61B 1.5B 1.5B 1.46B 1.41B 1.5B 1.65B 1.36B 1.54B 1.46B 1.79B 1.39B 1.43B 1.28B 2.29B 1.51B 1.67B 1.5B 1.79B 1.57B 1.62B 1.47B 1.8B 1.58B 1.64B 1.52B
Selling, General, and Administrative Revenue Growth +12.08% +2.32% +16.34% -0.92% +9.08% +1.46% +7.18% -6.71% +10.80% +5.36% +1.87% -0.59% +4.52% -3.61% +0.94% -6.77% +7.45% +0.40% +2.85% +3.00% -6.13% -8.57% +21.03% -11.48% +5.15% -18.53% +28.60% -2.52% +11.55% -44.09% +51.46% -9.09% +10.74% -15.95% +14.35% -3.53% +10.09% -18.04% +14.13% -3.65% +7.34% n/a
Research and Development Revenue 3.34B 2.73B 3.02B 2.73B 2.71B 2.52B 2.56B 2.41B 2.36B 1.99B 2B 1.8B 1.78B 1.61B 1.96B 1.71B 1.66B 1.67B 1.84B 1.47B 1.39B 1.39B 1.58B 1.38B 1.4B 1.23B 1.45B 1.28B 1.27B 1.11B 1.47B 1.34B 1.27B 1.26B 1.45B 1.24B 1.34B 1.22B 1.44B 1.14B 1.17B 1.04B
Research and Development Revenue Growth +22.04% -9.56% +10.55% +0.84% +7.47% -1.56% +6.38% +2.23% +18.71% -0.54% +10.70% +1.18% +10.67% -17.83% +14.90% +3.04% -1.02% -9.03% +25.43% +5.41% -0.14% -11.97% +14.52% -1.52% +13.95% -15.36% +13.50% +0.78% +14.76% -24.82% +9.94% +5.34% +1.10% -13.26% +17.32% -7.45% +9.41% -15.45% +26.31% -2.23% +12.53% n/a